A methodological perspective on genetic risk prediction studies in type 2 diabetes: Recommendations for future research

Current Diabetes Reports

Volumn 11, Issue 6, 2011, Pages 511-518

  Willems, Sara M ^a   Mihaescu, Raluca ^a   Sijbrands, Eric J G ^a   Van Duijn, Cornelia M ^a   Janssens, A Cecile J W ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Genetic predisposition; Prevention; Public health; Risk factors; Risk prediction; Type 2 diabetes

Indexed keywords

GLUCOSE;

BODY MASS; DIABETES CONTROL; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC MODEL; GENETIC RISK; GENETIC VARIABILITY; GLUCOSE BLOOD LEVEL; HIGH RISK POPULATION; HUMAN; MEDICAL RESEARCH; METHODOLOGY; NON INSULIN DEPENDENT DIABETES MELLITUS; POPULATION RESEARCH; PREDICTIVE VALUE; PREDICTOR VARIABLE; RECEIVER OPERATING CHARACTERISTIC; REVIEW; RISK ASSESSMENT; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM;

DIABETES MELLITUS, TYPE 2; GENETIC PREDISPOSITION TO DISEASE; HUMANS; PUBLIC HEALTH; RISK FACTORS;

EID: 80755140152     PISSN: 15344827     EISSN: 15390829     Source Type: Journal    
DOI: 10.1007/s11892-011-0235-6     Document Type: Review

References (44)

1. U.S. Census Bureau: General demographic characteristics, 2009 population estimates, United States. Available at http://factfinder.census.gov/servlet/ QTTable?-ds-name=PEP-2009-EST&-qr-name=PEP-2009-EST-DP1&-geo-id=01000US. Accessed June 2011.
2. Centers for Disease Control and Prevention: Percentage of civilian, noninstitutionalized population with diagnosed diabetes, by age, United States, 1980-2009. Available at http://www.cdc.gov/diabetes/statistics/prev/national/ figbyage.htm. Accessed June 2011.
3. Centers for Disease Control and Prevention: Age-adjusted percentage of civilian noninstitutionalized population with diagnosed diabetes, by sex, United States, 1980-2009. Available at http://www.cdc.gov/diabetes/statstics/prev/ national/figbysex.htm. Accessed June 2011.
4. Centers for Disease Control and Prevention: Prevalence of overweight, obesity, and extreme obesity among adults: United States, trends 1976-1980 through 2007-2008. Available at http://www.cdc.gov/nchs/data/hestat/obesity- adult-07-08/obesity-adult-07-08.pdf. Accessed June 2011.
5. KM Flegal MD Carroll CL Ogden, et al. 2010 Prevalence and trends in obesity among US adults, 1999-2008 JAMA 303 235 41 20071471 10.1001/jama.2009. 2014 1:CAS:528:DC%2BC3cXptVyksA%3D%3D
6. NT Nguyen XT Nguyen J Lane, et al. 2011 Relationship between obesity and diabetes in a US adult population: findings from the National Health and Nutrition Examinaton Survey, 1999-2006 Obes Surg 21 351 5 21128002 10.1007/s11695-010-0335-4
7. A Karve RA Hayward 2010 Prevalence, diagnosis, and treatment of impaired fasting glucose and impaired glucose tolerance in nondiabetic U.S. adults Diabetes Care 33 2355 9 20724649 10.2337/dc09-1957
8. HC Gerstein P Santaguida P Raina, et al. 2007 Annual incidence and relative risk of diabetes in people with various categories of dysglycemia: a systematic overview and meta-analysis of prospective studies Diabetes Res Clin Pract 78 305 12 17601626 10.1016/j.diabres.2007.05.004 (Pubitemid 350030320)
9. E Selvin MW Steffes H Zhu, et al. 2010 Glycated hemoglobin, diabetes, and cardiovascular risk in nondiabetic adults N Engl J Med 362 800 11 20200384 10.1056/NEJMoa0908359 1:CAS:528:DC%2BC3cXivV2hu7Y%3D
10. CM Alexander PB Landsman SM Teutsch, et al. 2003 NCEP-defined metabolic syndrome, diabetes, and prevalence of coronary heart disease among NHANES III participants age 50 years and older Diabetes 52 1210 4 12716754 10.2337/diabetes.52.5.1210 1:CAS:528:DC%2BD3sXjsFGhur0%3D (Pubitemid 36523358)
11. CL Gillies KR Abrams PC Lambert, et al. 2007 Pharmacological and lifestyle interventions to prevent or delay type 2 diabetes in people with impaired glucose tolerance: systematic review and meta-analysis BMJ 334 299 17237299 10.1136/bmj.39063.689375.55 (Pubitemid 46293963)
12. S Colagiuri 2011 Epidemiology of prediabetes Med Clin North Am 95 299 307 21281834 10.1016/j.mcna.2010.11.003
13. MI McCarthy 2011 From hype to hope? A journey through the genetics of type 2 diabetes Diabet Med 28 132 40 21219419 10.1111/j.1464-5491.2010.03194.x 1:STN:280:DC%2BC3M7gtlSmtQ%3D%3D
14. MI McCarthy 2010 Genomics, type 2 diabetes, and obesity N Engl J Med 363 2339 50 21142536 10.1056/NEJMra0906948 1:CAS:528:DC%2BC3cXhsFGkt7zO
15. International Diabetes Federation: Diabetes and impaired glucose tolerance. Global burden: prevalence and projections, 2010 and 2030. Available at: http://www.idf.org/diabetesatlas/diabetes-and-impaired-glucose-tolerance. Accessed June 2011.
16. M Stumvoll BJ Goldstein TW van Haeften 2005 Type 2 diabetes: principles of pathogenesis and therapy Lancet 365 1333 46 15823385 10.1016/S0140-6736(05) 61032-X 1:CAS:528:DC%2BD2MXjtF2iu7g%3D
17. B Paulweber P Valensi J Lindström, et al. 2010 A European evidence-based guideline for the prevention of type 2 diabetes Horm Metab Res 42 Suppl 1 S3 36 20391306 10.1055/s-0029-1240928 1:CAS:528:DC%2BC3cXmtVWntbY%3D
18. T Saaristo M Peltonen J Lindström, et al. 2005 Cross-sectional evaluation of the Finnish Diabetes Risk Score: a tool to identify undetected type 2 diabetes, abnormal glucose tolerance and metabolic syndrome Diab Vasc Dis Res 2 67 72 16305061 10.3132/dvdr.2005.011 (Pubitemid 40826998)
19. KE Heikes DM Eddy B Arondekar, et al. 2008 Diabetes Risk Calculator: a simple tool for detecting undiagnosed diabetes and prediabetes Diabetes Care 31 1040 5 18070993 10.2337/dc07-1150
20. ACJW Janssens MJ Khoury 2010 Assessment of improved prediction beyond traditional risk factors - when does a difference make a difference? Circ Cardiovasc Genet 3 3 5 20160189 10.1161/CIRCGENETICS.110.938092
21. PWF Wilson JB Meigs L Sullivan, et al. 2007 Prediction of incident diabetes mellitus in middle-aged adults Arch Intern Med 167 1068 74 17533210 10.1001/archinte.167.10.1068 (Pubitemid 46835795)
22. MF Hivert KA Jablonski L Perreault, et al. 2011 Updated genetic score based on 34 confirmed type 2 diabetes loci is associated with diabetes incidence and regression to normoglycemia in the Diabetes Prevention Program Diabetes 60 1340 8 21378175 10.2337/db10-1119 1:CAS:528:DC%2BC3MXms1Wkt7o%3D This study investigated effectiveness of preventive interventions in individuals in all quartiles of genetic risk estimated by a genetic risk score. This is very interesting from a public health perspective.
23. B Balkau C Lange L Fezeu, et al. 2008 Predicting diabetes: clinical, biological, and genetic approaches: data from the Epidemiological Study on the Insulin Resistance Syndrome (DESIR) Diabetes Care 31 2056 61 18689695 10.2337/dc08-0368 1:CAS:528:DC%2BD1cXht1Kksb7I
24. V Lyssenko P Almgren D Anevski, et al. 2005 Genetic prediction of future type 2 diabetes PLoS Med 2 e345 17570749 10.1371/journal.pmed.0020345 This was the first paper in T2D that considered the combined effect of multiple susceptibility variants in the prediction of disease risk. (Pubitemid 43020989)
25. ACJW Janssens M Gwinn S Subramonia-Iyer, et al. 2006 Does genetic testing really improve the prediction of future type 2 diabetes? PLoS Med 3 e114 16492078 10.1371/journal.pmed.0030114 (Pubitemid 43362887)
26. MN Weedon MI McCarthy G Hitman, et al. 2006 Combining information from common type 2 diabetes risk polymorphisms improves disease prediction PLoS Med 3 e374 17020404 10.1371/journal.pmed.0030374 (Pubitemid 44721826)
27. M Vaxillaire J Veslot C Dina, et al. 2008 Impact of common type 2 diabetes risk polymorphisms in the DESIR prospective study Diabetes 57 244 54 17977958 10.2337/db07-0615 1:CAS:528:DC%2BD1cXmt1ajsg%3D%3D
28. MC Cornelis L Qi C Zhang, et al. 2009 Joint effects of common genetic variants on the risk for type 2 diabetes in U.S. men and women of European ancestry Ann Intern Med 150 541 50 19380854
29. V Lyssenko A Jonsson P Almgren, et al. 2008 Clinical risk factors, DNA variants, and the development of type 2 diabetes N Engl J Med 359 2220 32 19020324 10.1056/NEJMoa0801869 1:CAS:528:DC%2BD1cXhtl2gurnF
30. S Cauchi D Meyre E Durand, et al. 2008 Post genome-wide association studies of novel genes associated with type 2 diabetes show gene-gene interaction and high predictive value PLoS One 3 e2031 18461161 10.1371/journal.pone.0002031 (Pubitemid 352025089)
31. X Lin K Song N Lim, et al. 2009 Risk prediction of prevalent diabetes in a Swiss population using a weighted genetic score-the CoLaus Study Diabetologia 52 600 8 19139842 10.1007/s00125-008-1254-y 1:CAS:528:DC%2BD1MXisFSjurg%3D
32. B Fontaine-Bisson F Renström O Rolandsson, et al. 2010 Evaluating the discriminative power of multi-trait genetic risk scores for type 2 diabetes in a northern Swedish population Diabetologia 53 2155 62 20571754 10.1007/s00125-010-1792-y 1:CAS:528:DC%2BC3cXhtV2gtrnK
33. M van Hoek A Dehghan JCM Witteman, et al. 2008 Predicting type 2 diabetes based on polymorphisms from genome-wide association studies: a population-based study Diabetes 57 3122 8 18694974 10.2337/db08-0425
34. H Lango UKTDG Consortium CNA Palmer, et al. 2008 Assessing the combined impact of 18 common genetic variants of modest effect sizes on type 2 diabetes risk Diabetes 57 3129 35 18591388 10.2337/db08-0504 1:CAS:528: DC%2BD1MXhsleisL4%3D
35. JB Meigs P Shrader LM Sullivan, et al. 2008 Genotype score in addition to common risk factors for prediction of type 2 diabetes N Engl J Med 359 2208 19 19020323 10.1056/NEJMoa0804742 1:CAS:528:DC%2BD1cXhtl2gurnE
36. T Sparso N Grarup C Andreasen, et al. 2009 Combined analysis of 19 common validated type 2 diabetes susceptibility gene variants shows moderate discriminative value and no evidence of gene-gene interaction Diabetologia 52 1308 14 19404609 10.1007/s00125-009-1362-3 1:STN:280:DC%2BD1MzosF2lsA%3D%3D
37. J Wang A Stancakova J Kuusisto, et al. 2010 Identification of undiagnosed type 2 diabetic individuals by the finnish diabetes risk score and biochemical and genetic markers: a population-based study of 7232 Finnish men J Clin Endocrinol Metab 95 3858 62 20463095 10.1210/jc.2010-0012 1:CAS:528: DC%2BC3cXhtVGktrbL
38. MB Schulze C Weikert T Pischon, et al. 2009 Use of multiple metabolic and genetic markers to improve the prediction of type 2 diabetes: the EPIC-Potsdam Study Diabetes Care 32 2116 9 19720844 10.2337/dc09-0197
39. PJ Talmud AD Hingorani JA Cooper, et al. 2010 Utility of genetic and non-genetic risk factors in prediction of type 2 diabetes: Whitehall II prospective cohort study BMJ 340 b4838 20075150 10.1136/bmj.b4838 This study is a very good example of a genetic risk prediction study, with a very complete description of the study population and a thorough assessment of the predictive ability.
40. JM de Miguel-Yanes P Shrader MJ Pencina, et al. 2011 Genetic risk reclassification for type 2 diabetes by age below or above 50 years using 40 type 2 diabetes risk single nucleotide polymorphisms Diabetes Care 34 121 5 20889853 10.2337/dc10-1265
41. K Miyake W Yang K Hara, et al. 2009 Construction of a prediction model for type 2 diabetes mellitus in the Japanese population based on 11 genes with strong evidence of the association J Hum Genet 54 236 41 19247372 10.1038/jhg.2009.17 1:CAS:528:DC%2BD1MXmvVWju70%3D
42. C Hu R Zhang C Wang, et al. 2009 PPARG, KCNJ11, CDKAL1, CDKN2A-CDKN2B, IDE-KIF11-HHEX, IGF2BP2 and SLC30A8 are associated with type 2 diabetes in a Chinese population PLoS One 4 e7643 19862325 10.1371/journal.pone.0007643
43. R Mihaescu J Meigs E Sijbrands, et al. 2011 Genetic risk profiling for type 2 diabetes PloS Curr 3 RRN1208 21278902 10.1371/currents.RRN1208 This paper is regularly updated and gives an overview of all genetic risk prediction studies conducted in T2D.
44. AC Janssens JP Ioannidis CM van Duijn, et al. 2011 Strengthening the reporting of genetic risk prediction studies: the GRIPS statement Eur J Epidemiol 26 255 9 21431409 10.1007/s10654-011-9552-y This paper describes reporting guidelines to enhance the transparency, quality, and completeness of the reporting of genetic risk prediction studies. A longer paper with examples and explanations was published simultaneously.